NSE Closed
Markets
NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%HDFCBANK7530.65%BHARTIARTL1,970.50.08%INFY1,1804.42%TCS2,473.74.57%NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%HDFCBANK7530.65%BHARTIARTL1,970.50.08%INFY1,1804.42%TCS2,473.74.57%
HomeSymbolJUBLPHARMA

Jubilant Pharmova Ltd.

NSE · JUBLPHARMA · jubilantpharmova.com
₹933.15
Last close · NSE/BSE
Set alert
Fundamentals
Mkt Cap
₹14,863.32 Cr
52W High
₹1,184.8
52W Low
₹786.05
P/E
123.6
EPS
₹7.55
Book Value
₹448.91
ROE
0.06%
ROCE
2.88%
ROA
0.03%
Profit margin
0.05%
Debt/Equity
0.51
P/B
2.08
Div Yield
0.01%
Rev. growth
7.93%
Sector
Pharmaceuticals
Ratios
Debtor days
45.0
Inventory days
57.0
Payable days
50.7
Cash conversion
51.3
Working cap. days
101.9
Interest coverage
3.6×
Dividend payout
Technicals · Members only

Unlock the technical read on $JUBLPHARMA — RSI, MACD, moving averages and intraday pivot levels — free when you sign in.

  • RSI, MACD & trend strength (ADX)
  • Price vs 20/50/100/200-day averages
  • Support & resistance pivot levels
Sign in to unlock — freeCreate an account
Premium market data is free for bulls.plus members — just sign up and verify your email. For information only — not investment advice.
Shareholding · 2026-06
Promoter 47.68%FII 15.87%DII 12.40%Public 24.05%Pledge 6.58%Shareholders 82,703
Shareholding pattern
Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24
Promoter47.68%47.68%47.68%47.68%47.68%50.68%50.68%50.68%50.68%50.68%
— of which pledged6.58%5.40%5.40%5.40%0.00%0.00%0.00%0.00%0.00%0.00%
FII15.87%15.90%15.96%16.57%17.40%17.22%16.96%17.94%19.49%19.06%
DII12.40%11.62%11.22%10.52%9.53%7.05%6.98%5.66%4.07%3.78%
Public24.05%24.80%25.14%25.23%25.39%25.06%25.39%25.72%25.76%26.48%
Others6.89%7.23%7.29%7.22%7.42%7.31%7.30%7.63%7.97%7.77%
No. of shareholders82,70386,34790,13393,33699,67396,5261,02,44289,45681,99292,264
Quarterly SEBI shareholding filings (CMOTS). Latest 10 of 41 quarters shown.
Financials
₹ CrFY26FY26FY25FY25FY25FY25FY25
Revenue₹70.3₹82,79,60,00,000₹67.3₹66.4₹59.5₹7,291.3₹60.7
EBIT₹13.7₹0₹11₹11₹9.5₹861.9₹9.7
PBT₹980.6
Net Profit₹57.2₹3,98,50,00,000₹6.6₹-6.4₹5.8₹839.4₹13.6
EPS (₹)₹52.85
Figures in ₹ crore · CMOTS fundamentals via api.ipo.plus
Company details
Shyam S BhartiaChairman (Non-Executive)
Hari S BhartiaCo-Chairman
Vivek MehraIndependent Director
SUSHIL KUMAR ROONGTAIndependent Director
Priyavrat BhartiaManaging Director
Arjun Shanker BhartiaJoint Managing Director
Arun SethIndependent Director
Shirish Gundopant BelapureIndependent Director
Ramakrishnan ArulWhole-time Director
Harsh MahajanIndependent Director
Shivpriya NandaIndependent Director
Arvind ChokhanyWhole Time Director
Naresh Kapoor.Company Sec. & Compli. Officer
Corporate actions
forthcoming Board MeetingsEx 2026-08-07
forthcoming Dividend (5/- per share)Ex 2026-07-24
dividend ₹5 (500%)Ex 2026-07-24
dividend ₹5 (500%)Ex 2025-07-25
Community sentiment · No signal
How do you feel about $JUBLPHARMA? · 0 bull · 0 bear
Message volume
0
Quiet · 0 in 24h
Participation
· 0 accounts
Sentiment trend (30d)
Not enough history yet — building the sentiment trend.

$JUBLPHARMA · Community

0 posts
No posts in $JUBLPHARMA yet. Start the conversation.